longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AKESO

09926

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -87.93, within the reasonable range, cheaper than 77.16% of the time in the past 5 years, and the industry ranks 74/78, the industry Median -5.43.

-87.93xP/E
HK$106.30Stock price
HK$-1.21Earnings per share
-87.93xP/E
Stock priceHK$106.30Earnings per shareHK$-1.21

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-25.82x
Typical range
-102.97x–15.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0163326489652

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-87.93x83.36%HK$97.92B
09688HKZAI LAB
-15.71x505.86%HK$23.19B
07666HKMETIS TECHBIO-P
-46.46x96.70%HK$18.91B
01877HKJUNSHI BIO
-40.71x84.85%HK$18.84B
09606HKDUALITYBIO-B
-11.11x85.58%HK$18.39B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
06855HKASCENTAGE
-6.71x18.21%HK$11.34B
02595HKGENFLEET-B
-7.48x78.96%HK$11.33B
09887HKLEADS BIOLABS-B
-32.61x8.67%HK$10.02B
01952HKEVEREST MED
-159.76x324.61%HK$9.92B
02493HKMABWELL-B
-8.52x--HK$9.22B
06938HKRIBOLIFE-B
-47.19x29.88%HK$9.22B
02616HKCSTONE PHARMA-B
-18.39x1.72%HK$8.88B
01672HKASCLETIS-B
-12.82x78.59%HK$8.73B
09966HKALPHAMAB-B
-38.40x--HK$7.78B
01779HKLONGBIO-B
-30.88x--HK$7.69B
02171HKCARSGEN-B
-72.05x51.12%HK$7.40B
02335HKMICOT PHARMA-B
-16.33x37.50%HK$6.85B
02256HKABBISKO-B
-11.63x300.95%HK$6.25B
06872HKTENNOR THERAP-B
-37.88x--HK$6.08B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.